Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Northrop Grumman
NOC
$68.3B
| $1.81B | 0.1% |
3,562,274
-46,464
| -1% | -$26.8M |
2013 Q2
52 quarters
|
|
177
Chubb
CB
$132B
| $1.8B | 0.1% |
5,286,296
+260,695
| +5% | +$85M |
2013 Q2
52 quarters
|
|
178
Capital One
COF
$122B
| $1.76B | 0.09% |
8,768,807
-161,543
| -2% | -$30.9M |
2013 Q2
52 quarters
|
|
179
iShares MSCI ACWI ETF
ACWI
$33.3B
| $1.76B | 0.09% |
11,192,473
+474,558
| +4% | +$72.5M |
2013 Q2
52 quarters
|
|
180
SLB Ltd
SLB
$72.6B
| $1.75B | 0.09% |
37,748,422
-2,411,140
| -6% | -$129M |
2013 Q2
52 quarters
|
|
181
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$44.4B
| $1.74B | 0.09% |
3,331,265
-337,622
| -9% | -$169M |
2013 Q2
52 quarters
|
|
182
Johnson Controls International
JCI
$95.4B
| $1.74B | 0.09% |
11,892,502
+126,752
| +1% | +$17.9M |
2013 Q2
52 quarters
|
|
183
iShares Gold Trust
IAU
$62.2B
| $1.74B | 0.09% |
22,991,594
-267,007
| -1% | -$22.7M |
2013 Q2
52 quarters
|
|
184
Emerson Electric
EMR
$90.3B
| $1.72B | 0.09% |
12,010,701
+360,639
| +3% | +$50.8M |
2013 Q2
52 quarters
|
|
185
State Street SPDR S&P Biotech ETF
XBI
$10B
| $1.71B | 0.09% |
10,834,146
-1,497,407
| -12% | -$202M |
2013 Q2
52 quarters
|
|
186
iShares MSCI USA Quality Factor ETF
QUAL
$48.8B
| $1.7B | 0.09% |
7,762,968
-1,302,676
| -14% | -$273M |
2013 Q4
50 quarters
|
|
187
United Rentals
URI
$65.8B
| $1.69B | 0.09% |
1,494,355
-251,212
| -14% | -$239M |
2013 Q2
52 quarters
|
|
188
Vanguard High Dividend Yield ETF
VYM
$80.5B
| $1.69B | 0.09% |
10,662,582
+308,016
| +3% | +$48.1M |
2013 Q2
52 quarters
|
|
189
Synopsys
SNPS
$97.7B
| $1.68B | 0.09% |
3,768,607
-147,224
| -4% | -$69.2M |
2013 Q2
52 quarters
|
|
190
Fidelity Total Bond ETF
FBND
$28B
| $1.67B | 0.09% |
36,816,208
+1,325,423
| +4% | +$60.5M |
2016 Q2
40 quarters
|
|
191
First Trust Rising Dividend Achievers ETF
RDVY
$25.3B
| $1.67B | 0.09% |
20,627,246
-251,198
| -1% | -$18.9M |
2014 Q4
46 quarters
|
|
192
Bristol-Myers Squibb
BMY
$121B
| $1.67B | 0.09% |
29,009,025
-189,529
| -0.6% | -$10.9M |
2013 Q2
52 quarters
|
|
193
Vanguard Total World Stock ETF
VT
$81.6B
| $1.67B | 0.09% |
10,646,703
+1,842,462
| +21% | +$281M |
2013 Q2
52 quarters
|
|
194
iShares Core S&P Total US Stock Market ETF
ITOT
$97.9B
| $1.67B | 0.09% |
10,164,560
-38,527
| -0.4% | -$6.12M |
2013 Q2
52 quarters
|
|
195
Quanta Services
PWR
$106B
| $1.66B | 0.09% |
2,311,374
+164,904
| +8% | +$113M |
2013 Q2
52 quarters
|
|
|
SPYM
196
State Street SPDR Portfolio S&P 500 ETF
SPYM
$177B
| $1.66B | 0.09% |
18,891,230
+1,641,458
| +10% | +$140M |
2013 Q4
50 quarters
|
|
197
Duke Energy
DUK
$91B
| $1.66B | 0.09% |
13,107,459
+427,628
| +3% | +$53.9M |
2013 Q2
52 quarters
|
|
|
FITB
198
Fifth Third Bancorp
FITB
$45.9B
| $1.66B | 0.09% |
29,374,537
+4,598,296
| +19% | +$233M |
2013 Q2
52 quarters
|
|
199
Invesco MSCI USA ETF
PBUS
$11.6B
| $1.65B | 0.09% |
22,037,615
-1,831,801
| -8% | -$133M |
2020 Q2
24 quarters
|
|
200
Vanguard Short-Term Treasury ETF
VGSH
$34.5B
| $1.65B | 0.09% |
28,332,310
+536,579
| +2% | +$31.3M |
2013 Q2
52 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.